Alyson Connor

Dr. Alyson Connor

Executive Director, Strategic Partnerships, Clinical Pharmacology

About

Dr. Alyson Connor has over 25 years of experience in the design and conduct of early-phase clinical programs, with emphasis on the use of adaptive and umbrella protocols to streamline the transition from first-in-human to proof-of-concept. 

At Quotient Sciences, Alyson has most recently led the global client services team and has significant experience in the areas of project management, research, and clinical pharmacology. Currently, Alyson is responsible for working with our internal and customer teams to identify and implement best practice approaches for the design, contracting, and delivery of early phase programs.

Alyson holds a PhD in Molecular Virology and a Bachelor of Science degree in Microbiology, both from Newcastle University.

Expertise & focus areas
Clinical Pharmacology Services
Clinical Pharmacology

Clinical Pharmacology Info Sheet

10 March 2025 Read More

Latest news from Quotient Sciences

More News
News & Announcements, Articles & Publications, commercial manufacturing, Dr. Helen Baker, Dr. Richard Castledine Dr. Helen Baker and Dr. Richard Castledine contribute to Pharmaceutical Technology's 'Poor API Quality Threatens a Healthy Supply' By: Dr. Helen Baker and Dr. Richard Castledine
Read More
News & Announcements, Articles & Publications, Thierry Van Nieuwenhove Thierry Van Nieuwenhove on the Future of CDMO Partnerships By: Thierry Van Nieuwenhove
Read More
News & Announcements, Translational Pharmaceutics®, Articles & Publications BioPharm International interviews Helen Baker about how Quotient Sciences is optimizing drug development
Read More